Prenatal screens revealed blood type O positive, antibody negative, Rubella immune, rapid plasma reagin nonreactive, hepatitis B surface antigen negative, and group B strep status unknown.
The pregnancy was complicated by preterm labor and cervical shortening requiring a cerclage placement.
She was also treated with terbutaline at 29 weeks gestation.
She received a complete course of betamethasone.
On the day of delivery, she presented in labor with cervical changes and was taken for cesarean section due to the known breech positioning of Twin II.
She was admitted to the Neonatal Intensive Care Unit for treatment of prematurity.
RESPIRATORY ISSUES:  The infant was on room air for her entire Neonatal Intensive Care Unit admission.
FLUIDS/ELECTROLYTES/NUTRITION ISSUES:  The infant was initially nothing by mouth and maintained on intravenous fluids.
Enteral feeds were started on day of life two and gradually advanced to full volume.
She required additional calories and was to be discharged home on breast milk 24 to 25 calories with 4 calories by Enfamil powder.
A blood culture was obtained prior to starting intravenous ampicillin and gentamicin.
The blood culture was no growth at 48 hours, and antibiotics were discontinued.
GASTROINTESTINAL ISSUES:  The infant required treatment for unconjugated hyperbilirubinemia with phototherapy.
Phototherapy was initiated and continued for approximately four days.
Her phototherapy was discontinued on [**2123-10-4**], and her rebound bilirubin the following day was 7.2 total bilirubin and a direct bilirubin of 0.2.
Medications:  Poly-Vi-[**Male First Name (un) **] 1 cc by mouth once per day; ferrous sulfate 25 mg/mL solution 0.2 cc by mouth once per day.
Immunizations:  Hepatitis B vaccine was administered on [**2123-10-4**].
IMMUNIZATIONS RECOMMENDED:  Synagis respiratory syncytial virus prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  (1) born at less than 32 weeks gestation.
Influenza immunization should be considered annually in the Fall for preterm infants with chronic lung disease once they reach six months of age.
Before this age, the family and other care givers should be considered for immunization against influenza to protect the infant.
